Lipopolysaccharides

"Lipopolysaccharides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)

Descriptor ID	D008070
MeSH Number(s)	D09.400.500 D09.698.718.450 D10.494 D23.050.161.616.525 D23.946.123.329.500
Concept/Terms	Lipopolysaccharides Lipopolysaccharides Lipoglycans

Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharides".

Chemicals and Drugs [D]
Carbohydrates [D09]
Glycoconjugates [D09.400]
Lipopolysaccharides [D09.400.500]
Polysaccharides [D09.698]
Polysaccharides, Bacterial [D09.698.718]
Lipopolysaccharides [D09.698.718.450]
Lipids [D10]
Lipopolysaccharides [D10.494]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Bacterial [D23.050.161]
Polysaccharides, Bacterial [D23.050.161.616]
Lipopolysaccharides [D23.050.161.616.525]
Toxins, Biological [D23.946]
Bacterial Toxins [D23.946.123]
Endotoxins [D23.946.123.329]
Lipopolysaccharides [D23.946.123.329.500]

Below are MeSH descriptors whose meaning is related to "Lipopolysaccharides".

Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharides".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipopolysaccharides" by people in this website by year, and whether "Lipopolysaccharides" was a major or minor topic of these publications.

Bar chart showing 140 publications over 29 distinct years, with a maximum of 10 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	2	2
1998	1	1	2
1999	0	1	1
2000	0	1	1
2001	1	3	4
2002	2	4	6
2003	5	5	10
2004	3	6	9
2005	1	4	5
2006	2	7	9
2007	2	4	6
2008	1	2	3
2009	0	3	3
2010	1	4	5
2011	2	5	7
2012	2	5	7
2013	1	3	4
2014	2	7	9
2015	1	6	7
2016	0	4	4
2017	1	7	8
2018	2	3	5
2019	2	2	4
2020	0	4	4
2021	0	1	1
2022	1	2	3
2023	2	2	4
2024	5	1	6

Below are the most recent publications written about "Lipopolysaccharides" by people in Profiles.

Khan M, Farooqi S, Mitchell KL, Chowdhury SKR, Cabrera-Ayala M, Huang J, Wallace DC, Weiss SL. Effect of sodium butyrate on kidney and liver mitochondrial dysfunction in a lipopolysaccharide mouse?model. FASEB J. 2024 Dec 15; 38(23):e70228.

View in: PubMed
Ritzenthaler JD, Watson WH, Roman J. a4 Nicotinic Acetylcholine Receptors in Lipopolysaccharide-Related Lung Inflammation. Int J Mol Sci. 2024 Oct 21; 25(20).

View in: PubMed
Yazdani R, Askari M, Ahmadi AM, Azizi G, Ciric B, Boehm A, Zhang GX, Rostami A. Mouse monocytes express CD127 by immune cells, not LPS. Front Immunol. 2024; 15:1356004.

View in: PubMed
Guo ZF, Tongmuang N, Li C, Zhang C, Hu L, Capreri D, Zuo MX, Summer R, Sun J. Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. JCI Insight. 2024 Sep 10; 9(17).

View in: PubMed
Pawar K, Kawamura T, Kirino Y. The tRNAVal half: A strong endogenous Toll-like receptor 7 ligand with a 5'-terminal universal sequence signature. Proc Natl Acad Sci U S A. 2024 May 07; 121(19):e2319569121.

View in: PubMed
Stueckle TA, Jensen J, Coyle JP, Derk R, Wagner A, Dinu CZ, Kornberg TG, Friend SA, Dozier A, Agarwal S, Gupta RK, Rojanasakul LW. In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approaches. Part Fibre Toxicol. 2024 03 21; 21(1):16.

View in: PubMed
Jacob S, Kosaka Y, Bhatlekar S, Denorme F, Benzon H, Moody A, Moody V, Tugolukova EA, Hull G, Kishimoto N, Manne BK, Guo L, Souvenir R, Seliger BJ, Eustes AS, Hoerger K, Tolley ND, Fatahian AN, Boudina S, Christiani DC, Wei Y, Ju C, Campbell RA, Rondina MT, Abel ED, Bray PF, Weyrich AS, Rowley JW. Mitofusin-2 Regulates Platelet Mitochondria and Function. Circ Res. 2024 01 19; 134(2):143-161.

View in: PubMed
Jain S, Saha P, Syamprasad NP, Panda SR, Rajdev B, Jannu AK, Sharma P, Naidu VGM. Targeting TLR4/3 using chlorogenic acid ameliorates LPS+POLY I:C-induced acute respiratory distress syndrome via alleviating oxidative stress-mediated NLRP3/NF-?B axis. Clin Sci (Lond). 2023 05 31; 137(10):785-805.

View in: PubMed
Zhang C, Guo ZF, Liu W, Kazama K, Hu L, Sun X, Wang L, Lee H, Lu L, Yang XF, Summer R, Sun J. PIMT is a novel and potent suppressor of endothelial activation. Elife. 2023 04 18; 12.

View in: PubMed
Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Role of CD14 in human disease. Immunology. 2023 07; 169(3):260-270.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement